Information Provided By: 
Fly News Breaks for September 13, 2016
BABY
Sep 13, 2016 | 07:11 EDT
As previously reported, Raymond James analyst Jayson Bedford upgraded Natus Medical to Outperform from Market Perform with a $46 price target. Bedford recently met with management and came away more confident that capital deployment will be larger than expected, potentially increasing earnings meaningfully and acting as a catalyst for shares. He believes Natus will likely add businesses that are adjacent to their core Neurology and Newborn businesses, and would not be surprised to see it carve out a non-core business from a larger entity.
News For BABY From the Last 2 Days
There are no results for your query BABY
